Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Annual Report 2002 - Essential Drugs and Medicines Policy: Supporting Countries to Close the Access Gap
(2003; 20 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentDeveloping a monitoring culture to improve impact
View the documentTraditional and complementary medicine: putting policy into action
View the documentKey country support in Africa and Eastern Mediterranean
View the documentWHO Collaborating Centres: supplying active support for medicines work
View the documentHow is TRIPS affecting access to medicines?
View the documentDevelopment of the essential drugs concept over the past 25 years
View the documentMeasuring access to antimalarials
View the documentStrengthening regional and national bulk procurement
View the documentLearning from successful supply systems
View the documentWorking out the cost of medicines
View the documentSupporting MDG target on access to essential medicines
View the documentCommon guideline for evaluating new medicines in Baltic countries
View the documentNGO toolkit for improving access to HIV/AIDS treatment
View the documentHarmonizing medicines regulation in the Americas
View the documentGood manufacturing practice in China: rapid progress
View the documentPharmacovigilance: detecting and reporting adverse drug reactions
View the documentVariations in prescribing information in 26 countries
View the document10th ICDRA: an international basis for medicines regulation
View the documentFighting poor-quality drugs
View the documentImproving medicines use in hospitals in Cambodia and Lao PDR
View the documentWHO-India Essential Drugs Programme: multiplying impact
View the documentOman: improving antibiotic use in primary health care

Good manufacturing practice in China: rapid progress

In the Annual Report 2001: Essential Drugs and Medicines Policy, the number of pharmaceutical manufacturers that would be compliant with good manufacturing practice (GMP) by the end of 2002 was estimated at 1200. In fact, by the end of 2002, 1600 pharmaceutical manufacturers were compliant with GMP. This rapid progress is due to China's concerted effort, with WHO assistance, to organize GMP training and to translate WHO's GMP basic training modules into Chinese (see: http://www.who.int/medicines/organization/qsm/activities/qualityassurance/gmp/trainingmodules/whobasictraining modulesgmp.htm). An article by K. Morimoto et al. entitled Promoting GMP implementation: developing training materials for the international audience, will appear in Quality Assurance: Good Practice, Regulation, and Law, 2003, 10(1).


to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017